CD8+ and CD8- NKT Cells Exhibit Phenotypic Changes During Pregnancy

References

• Abu-Raya B, Michalski C, Sadarangani M, Lavoie PM. 2020. Maternal immunological adaptation during normal pregnancy. Front Immunol. 11:2627.
   Web of Science ®Google Scholar
• Anderson AC, Joller N, Kuchroo VK. 2016. Lag-3, Tim-3, and TIGIT: co-inhibitory receptors with specialized functions in immune regulation. Immunity. 44(5):989–1004.
   PubMed Web of Science ®Google Scholar
• Bottino C, Castriconi R, Pende D, Rivera P, Nanni M, Carnemolla B, Cantoni C, Grassi J, Marcenaro S, Reymond N, et al. 2003. Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. J Exp Med. 198(4):557–67.
   PubMed Web of Science ®Google Scholar
• Boyson JE, Aktan I, Barkhuff DA, Chant A. 2008. NKT cells at the maternal-fetal interface. Immunol Invest. 37(5–6):565–82.
   PubMed Web of Science ®Google Scholar
• Cocks MM, Mills AM. 2021. The immune checkpoint inhibitor LAG-3 and its ligand GAL-3 in vulvar squamous neoplasia. Int J Gynecol Pathol. 41(2):113–121.
   Web of Science ®Google Scholar
• de Andrés C, Fernández-Paredes L, Tejera-Alhambra M, Alonso B, Ramos-Medina R, Sánchez-Ramón S. 2017. Activation of blood CD3 + CD56 + CD8 + T cells during pregnancy and multiple sclerosis. Front Immunol. 8:196.
   PubMed Web of Science ®Google Scholar
• Friedman LA, Ring KL, Mills AM. 2020. LAG-3 and GAL-3 in endometrial carcinoma: emerging candidates for immunotherapy. Int J Gynecol Pathol. 39(3):203–12.
   PubMed Web of Science ®Google Scholar
• Godfrey DI, Uldrich AP, McCluskey J, Rossjohn J, Moody DB. 2015. The burgeoning family of unconventional T cells. Nat Immunol. 16(11):1114–23.
   PubMed Web of Science ®Google Scholar
• Guo M, Yuan F, Qi F, Sun J, Rao Q, Zhao Z, Huang P, Fang T, Yang B, Xia J. 2020. Expression and clinical significance of LAG-3, FGL1, PD-L1 and CD8+T cells in hepatocellular carcinoma using multiplex quantitative analysis. J Transl Med. 18(1). doi:10.1186/s12967-020-02469-8
   Web of Science ®Google Scholar
• Hosseini S, Shokri F, Pour SA, Khoshnoodi J, Jeddi-Tehrani M, Zarnani AH. 2019. Diminished frequency of menstrual and peripheral blood NKT-Like cells in patients with unexplained recurrent spontaneous abortion and infertile women. Reprod Sci. 26(1):97–108.
   PubMed Web of Science ®Google Scholar
• Huang Z, Qi G, Miller JS, Zheng SG. 2020. CD226: an emerging role in immunologic diseases. Front Cell Dev Biol. 0:564.
   Google Scholar
• Konjevic G, Jurisic V, Jovic V, Vuletic A, Mirjacic Martinovic K, Radenkovic S, Spuzic I. 2012. Investigation of NK cell function and their modulation in different malignancies. Immunol Res. 52(1–2):139–56.
   PubMed Web of Science ®Google Scholar
• Konjević G, Vuletić A, Mirjačić Martinović K, Colović N, Čolović M, Jurišić V. 2016. Decreased CD161 activating and increased CD158a inhibitory receptor expression on NK cells underlies impaired NK cell cytotoxicity in patients with multiple myeloma. J Clin Pathol. 69(11):1009–16.
   Web of Science ®Google Scholar
• Lozano E, Dominguez-Villar M, Kuchroo V, Hafler DA. 2012. The TIGIT/CD226 axis regulates human T cell function. J Immunol. 188(8):3869–75.
   PubMed Web of Science ®Google Scholar
• Marrero I, Ware R, Kumar V. 2015. Type II NKT cells in inflammation, autoimmunity, microbial immunity, and cancer. Front Immunol. 6:6–11.
   PubMed Web of Science ®Google Scholar
• Mars LT, Laloux V, Goude K, Desbois S, Saoudi A, Van Kaer L, Lassmann H, Herbelin A, Lehuen A, Liblau RS. 2002. Cutting edge: vα14-Jα281 NKT cells naturally regulate experimental autoimmune encephalomyelitis in nonobese diabetic mice. J Immunol. 168(12):6007–11.
   PubMed Web of Science ®Google Scholar
• McBride MA, Patil TK, Bohannon JK, Hernandez A, Sherwood ER, Patil NK. 2020. Immune checkpoints: novel therapeutic targets to attenuate sepsis-induced immunosuppression. Front Immunol. 11:624272.
   PubMed Web of Science ®Google Scholar
• McCarthy C, Shepherd D, Fleire S, Stronge VS, Koch M, Illarionov PA, Bossi G, Salio M, Denkberg G, Reddington F, et al. 2007. The length of lipids bound to human CD1d molecules modulates the affinity of NKT cell TCR and the threshold of NKT cell activation. J Exp Med. 204(5):1131–44.
   PubMed Web of Science ®Google Scholar
• Meggyes M, Miko E, Lajko A, Csiszar B, Sandor B, Matrai P, Tamas P, Szereday L. 2019. Involvement of the PD-1/PD-L1 co-inhibitory pathway in the pathogenesis of the inflammatory stage of early-onset preeclampsia. Int J Mol Sci. 20(3):583.
   PubMed Web of Science ®Google Scholar
• Meggyes M, Miko E, Szigeti B, Farkas N, Szereday L. 2019. The importance of the PD-1/PD-L1 pathway at the maternal-fetal interface. BMC Pregnancy Childbirth. 19(1):74.
   PubMedGoogle Scholar
• Meggyes M, Szanto J, Lajko A, Farkas B, Varnagy A, Tamas P, Hantosi E, Miko E, Szereday L. 2018. The possible role of CD8+/Vα7.2+/CD161++ T (MAIT) and CD8+/Vα7.2+/CD161 lo T (MAIT-like) cells in the pathogenesis of early-onset pre-eclampsia. Am J Reprod Immunol. 79(2):e12805.
   Web of Science ®Google Scholar
• Miko E, Barakonyi A, Meggyes M, Szereday L. 2021. The role of Type I and Type II NKT cells in materno-fetal immunity. Biomedicines. 9:1901.
   PubMed Web of Science ®Google Scholar
• Miko E, Meggyes M, Doba K, Barakonyi A, Szereday L. 2019. Immune checkpoint molecules in reproductive immunology. Front Immunol. 10:846.
   PubMed Web of Science ®Google Scholar
• Miko E, Szereday L, Barakonyi A, Jarkovich A, Varga P, Szekeres-Bartho J. 2008. The role of invariant NKT cells in pre-eclampsia. Am J Reprod Immunol. 60(2):118–26.
   PubMed Web of Science ®Google Scholar
• Montoya CJ, Pollard D, Martinson J, Kumari K, Wasserfall C, Mulder CB, Rugeles MT, Atkinson MA, Landay AL, Wilson SB. 2007. Characterization of human invariant natural killer T subsets in health and disease using a novel invariant natural killer T cell-clonotypic monoclonal antibody, 6B11. Immunology. 122:1–14.
   PubMed Web of Science ®Google Scholar
• Mor G, Cardenas I, Abrahams V, Guller S. 2011. Inflammation and pregnancy: the role of the immune system at the implantation site. Ann N Y Acad Sci. 1221(1):80–87.
   PubMed Web of Science ®Google Scholar
• Murrieta-Coxca JM, Rodríguez-Martínez S, Cancino-Diaz ME, Markert UR, Favaro RR, Morales-Prieto DM. 2019. IL-36 cytokines: regulators of inflammatory responses and their emerging role in immunology of reproduction. Int J Mol Sci. 20(7):1649.
   PubMed Web of Science ®Google Scholar
• Orlova EG, Shirshev SV. 2009. Leptin as an immunocorrecting agent during normal pregnancy. Bull Exp Biol Med. 148(1):75–78.
   PubMed Web of Science ®Google Scholar
• Pellicci DG, Koay HF, Berzins SP. 2020. Thymic development of unconventional T cells: how NKT cells, MAIT cells and γδ T cells emerge. Nat Rev Immunol. 20(12):756–70.
   PubMed Web of Science ®Google Scholar
• R: a language and environment for statistical computing. https://www.r-project.org/
   Google Scholar
• Romero-Olmedo AJ, Schulz AR, Huber M, Brehm CU, Chang HD, Chiarolla CM, Bopp T, Skevaki C, Berberich-Siebelt F, Radbruch A, et al. 2021. Deep phenotypical characterization of human CD3 + CD56 + T cells by mass cytometry. Eur J Immunol. 51(3):672–81.
   PubMed Web of Science ®Google Scholar
• Singh AK, Tripathi P, Cardell SL. 2018. Type II NKT cells: an elusive population with immunoregulatory properties. Front Immunol. 9:1969.
   PubMed Web of Science ®Google Scholar
• Triebel F, Jitsukawa S, Baixeras E, Roman-Roman S, Genevee C, Viegas-Pequignot E, Hercend T. 1990. LAG-3, a novel lymphocyte activation gene closely related to CD4. J Exp Med. 171(5):1393–405.
   PubMed Web of Science ®Google Scholar
• Vuletić A, Jurišić V, Jovanić I, Milovanović Z, Nikolić S, Konjević G. 2013. Distribution of several activating and inhibitory receptors on CD3−CD56+ NK cells in regional lymph nodes of melanoma patients. J Surg Res. 183(2):860–68.
   PubMed Web of Science ®Google Scholar
• Wagner AK, Kadri N, Snäll J, Brodin P, Gilfillan S, Colonna M, Bernhardt G, Höglund P, Kärre K, Chambers BJ. 2017. Expression of CD226 is associated to but not required for NK cell education. Nat Commun. 8(1):1–14.
   PubMedGoogle Scholar
• Wang J, Sanmamed MF, Datar I, Su TT, Ji L, Sun J, Chen L, Chen Y, Zhu G, Yin W, et al. 2019. Fibrinogen-Like Protein 1 is a major immune inhibitory ligand of LAG-3. Cell. 176(1–2):334–47.e12.
   PubMed Web of Science ®Google Scholar
• Yeo J, Ko M, Lee DH, Park Y, Jin HS. 2021. Tigit/cd226 axis regulates anti-tumor immunity. Pharmaceuticals. 14(3):1–20.
   Web of Science ®Google Scholar
• Yuan J, Li J, Huang SY, Sun X. 2015. Characterization of the subsets of human NKT-like cells and the expression of Th1/Th2 cytokines in patients with unexplained recurrent spontaneous abortion. J Reprod Immunol. 110:81–88.
   PubMed Web of Science ®Google Scholar